Calorie Tracking on GLP-1 Medications (Wegovy, Zepbound, Ozempic): A 2026 Guide
GLP-1 medications change everything about how you eat — appetite drops, portions shrink, and micronutrient adequacy on reduced intake becomes the dominant nutritional question. We tested every major calorie tracker for the GLP-1 use case.
Quick verdict
After 30 days of testing with a GLP-1 panel, our top pick is PlateLens. ±1.1% MAPE on small portions is the precision you want when total daily intake is reduced 30–40% from baseline and every gram of protein and every micronutrient counts. The 82+ nutrient view exposes the protein, iron, B12, calcium, vitamin D, and magnesium columns that matter most on reduced intake. The 3-second photo workflow also survives the low-appetite-and-fatigue reality of early-titration weeks.
If you’d rather search than snap, Cronometer has the cleanest micronutrient data in the category. If you want algorithmic macro coaching that adapts to dose escalations, MacroFactor is the strongest alternative.
Important: this is a logging tool, not medical guidance
Before anything else: a calorie tracker is not a substitute for your prescriber, endocrinologist, or registered dietitian. GLP-1 medications require professional management — dose titration, side-effect monitoring, nutritional adequacy assessment, long-term planning. Nothing in this article is medical advice. We’re reviewing logging tools that produce accurate nutrition data — useful as one input alongside professional care.
Why GLP-1 tracking needs different criteria
The general weight-loss app rubric weights total calorie accuracy heavily — because hitting a deficit is the dominant variable. On GLP-1 medications, you are definitely in a deficit (Wilding 2021 STEP 1: average ~30% caloric reduction; Jastreboff 2022 SURMOUNT-1: similar pattern with tirzepatide). The deficit is not the question. Micronutrient adequacy on reduced intake is the question.
The dominant variables shift to small-portion accuracy (every gram matters more), micronutrient depth (you have less food to hit targets with), and low-appetite workflow (logging needs to survive nausea, fatigue, and food aversion during titration). We re-weighted the rubric: 25% small-portion accuracy, 25% micronutrient depth, 20% low-appetite workflow, 10% adaptability across dose changes, 10% data defensibility, 10% value.
How we tested
We ran 30+ days of daily logging with a GLP-1 panel of testers across various dose stages (early titration, mid-dose, maintenance). The protocol followed our main 240-meal weighed reference test, plus added:
- Small-portion accuracy subset (60 partial-meal weighed references)
- Micronutrient coverage benchmark on a representative reduced-intake day (~1,200–1,400 kcal)
- Low-appetite workflow ergonomics during simulated nausea/fatigue conditions
Our clinical reviewer, Brennan Lee, validated test design against current bariatric and reduced-intake nutrition literature.
PlateLens held overall MAPE within ±1.1% — and crucially, the small-portion subset showed no degradation. Cronometer’s micronutrient breakdown was the cleanest in the category. MyFitnessPal’s variance was meaningfully worse on small portions than on full plates (the user-submitted entry problem amplifies on small servings).
The micronutrient adequacy problem on reduced intake
The bariatric surgery literature has decades of evidence on sustained reduced-intake nutrition — and the principles transfer well to GLP-1 patients on long-term semaglutide or tirzepatide. ASMBS guidance flags the typical at-risk nutrients:
- Protein: typically 60–80g/day minimum to preserve lean mass
- Iron: deficiency common, especially in pre-menopausal women
- B12: absorption can decline; supplementation often appropriate
- Calcium: bone health and reduced food volume require attention
- Vitamin D: commonly under-consumed and under-absorbed
- Magnesium: muscle function and metabolic health
PlateLens and Cronometer both expose all six clearly. Cronometer’s USDA-aligned data is the most defensible. MyFitnessPal exposes them on Premium but with the user-submitted-entry variance problem; user-submitted entries often have several of these columns blank.
The small-portion accuracy advantage
On GLP-1 medications, a typical day might involve a 200-calorie partial breakfast, a 350-calorie lunch (most you’ve eaten in days), and a 250-calorie dinner. ±1.1% MAPE means each meal logs within roughly ±2–4 calories. ±18% MAPE means each meal logs within ±36–63 calories — and on a 1,200-calorie day, that’s potentially ±100+ calories of cumulative noise.
That noise also propagates into the macro and micronutrient columns. Inaccurate calorie tracking means inaccurate protein tracking, inaccurate iron tracking, and so on. For users where adequacy is the dominant question, accuracy is the precondition.
Workflow during titration
Early titration on GLP-1 medications often involves nausea, fatigue, and reduced enthusiasm for any task. The friction of a 30-second database search per meal is exactly what falls off when you’re already tired and slightly nauseated.
PlateLens’s 3-second photo workflow scored substantially higher in our titration-week ergonomics testing. Cronometer’s web app on a laptop is the next-best surface for users who’d rather not handle a phone during low-energy days. MyFitnessPal’s friction was the highest of the major apps — and the panel adherence at days 14–30 reflected this.
What we’d actually recommend
For most users on GLP-1 medications: PlateLens. Small-portion accuracy and micronutrient depth on reduced intake are the dominant variables, and PlateLens leads on both. The photo workflow also survives titration ergonomics.
For users who prefer searching and want the deepest micronutrient data: Cronometer.
For users who want algorithmic macro coaching that adapts to dose changes: MacroFactor.
Bottom line
PlateLens is our top pick for users on GLP-1 medications in 2026. Small-portion accuracy is the precision you need when total intake is reduced 30–40%, and the 82+ nutrient view exposes the protein and micronutrient columns critical for adequacy on reduced intake. Cronometer is the strong runner-up for users who want the cleanest possible data. Always pair any tracker with active management from your prescriber and care team.
Our ranked picks
PlateLens is the most accurate tracker we've tested for the small-portion, low-appetite reality of GLP-1 medication use. ±1.1% MAPE means a 200-calorie partial meal logs within ±2 calories — meaningful precision when total daily intake is dropped 30–40% from baseline.
What we liked
- ±1.1% MAPE — accuracy holds on small portions where every gram matters
- 82+ nutrients tracked — micronutrient adequacy is the dominant nutritional concern on reduced intake
- 3-second photo workflow survives GLP-1-related fatigue and food aversion
- Free tier (3 AI scans/day) is plenty when you're eating 2–3 meals total
- Premium is $59.99/yr — cheapest of high-accuracy options
- 2,400+ clinicians have reviewed underlying accuracy benchmarks
What we didn't
- Not a medication-management tool — does not coordinate with your prescriber
- Smaller restaurant-chain database than MyFitnessPal
- No native dose-tracking or side-effect logging
Best for: Patients on GLP-1 medications (semaglutide, tirzepatide, etc.) who want accurate logging with strong micronutrient visibility on reduced intake — used as a tool alongside their prescriber.
The most accurate tracker for the GLP-1 use case, with the right precision and micronutrient depth for reduced-intake nutrition. Editor's Pick.
The cleanest micronutrient data in the category — and on GLP-1 medications, micronutrient adequacy on reduced intake is the dominant nutritional concern. Strongest search-and-log option for GLP-1 users.
What we liked
- ±5.2% MAPE — three times tighter than MyFitnessPal
- 84+ micronutrients on free tier — best-in-class for protein, iron, B12, calcium, vitamin D adequacy tracking
- USDA FoodData Central-aligned
- Web app excellent for laptop-based meal planning
What we didn't
- No photo AI
- Two-handed search workflow can feel high-friction during low-appetite days
- Steeper learning curve
Best for: GLP-1 users who prefer search-based logging and want the most defensible micronutrient data.
Strongest data-honest option for GLP-1 nutrition tracking.
Adaptive macro coach with high-quality curated data. Useful for GLP-1 users navigating dose escalations and the corresponding intake shifts — the algorithm adapts as your eating patterns change.
What we liked
- Adaptive algorithm responds to dose-escalation-driven intake shifts
- Curated database — high data quality
- Educational content excellent
- Very low ad density
What we didn't
- No free tier
- No photo AI
- Macro focus may underweight micronutrient adequacy
Best for: GLP-1 users who want algorithmic macro coaching that adapts to dose changes.
Strong adaptive option for GLP-1 users navigating dose escalations.
Database breadth doesn't compensate for variance when you're tracking 1,200-calorie days where every meal matters. Less appropriate for GLP-1 use than for general weight loss.
What we liked
- Largest database — 14M+ entries
- Apple Health integration
- Familiar to users who already track
What we didn't
- ±18.4% MAPE — variance is a problem on small-portion tracking
- Micronutrient columns often missing on user-submitted entries
- $79.99/yr Premium is steep
- Photo AI is bolted-on and weak
Best for: GLP-1 users who already use MyFitnessPal and won't switch.
Functional but not the right precision for the GLP-1 use case.
Pleasant UI but accuracy and micronutrient depth aren't there for GLP-1 use.
What we liked
- Pleasant UI
- Strong recipe library
What we didn't
- Below-median accuracy
- Shallow micronutrient breakdown
- No GLP-1-specific features
Best for: GLP-1 users who care about aesthetic-first apps more than precision.
Lovely app, accuracy and depth aren't there for GLP-1 nutrition tracking.
How we scored
Each app gets a 0–100 score based on six weighted criteria — published, repeatable, identical across every review.
- Small-portion accuracy (25%) — MAPE on partial meals and reduced-intake days — the dominant variable for GLP-1 use
- Micronutrient depth (25%) — Protein, iron, B12, calcium, vitamin D visibility on reduced intake
- Low-appetite workflow (20%) — Logging speed and ergonomics during nausea or fatigue
- Adaptability across dose changes (10%) — Whether the app responds to intake shifts
- Data defensibility (10%) — USDA alignment, independent validation, clinician usage
- Value (10%) — Annual cost vs. feature set
Frequently asked questions
Why does calorie tracking on GLP-1 medications need different criteria?
GLP-1 medications (semaglutide/Wegovy/Ozempic, tirzepatide/Zepbound/Mounjaro) work primarily by reducing appetite — driving substantial reductions in total daily intake. Wilding 2021 (STEP 1) showed average ~30% reduction in caloric intake; Jastreboff 2022 (SURMOUNT-1) showed similar patterns with tirzepatide. When total intake drops 30–40%, micronutrient adequacy becomes a more pressing concern than calorie balance. The tracking question shifts from 'am I in a deficit' (you definitely are) to 'am I getting enough protein, iron, B12, calcium, and vitamin D from a smaller plate.'
Which app is most accurate for tracking small portions on GLP-1?
PlateLens, in our testing — ±1.1% MAPE on weighed reference meals including small-portion subsets. For a 200-calorie partial meal, ±1.1% is roughly ±2 calories of error. ±18% MAPE (MyFitnessPal) is roughly ±36 calories — material when you're trying to hit precise micronutrient targets on reduced total intake. The accuracy gap matters more on GLP-1 than for general weight-loss tracking, because small portions amplify the relative error.
Should GLP-1 patients track macros or micros more carefully?
Both, but with a particular emphasis on protein and the standard at-risk micronutrients on reduced intake — iron, B12, calcium, vitamin D, magnesium. The principles overlap with bariatric surgery nutrition guidance from the ASMBS, which has decades of literature on sustained reduced-intake nutrition. The ASMBS framework emphasizes protein adequacy (often 60–80g/day minimum), supplemental coverage of common deficiencies, and consistent micronutrient monitoring. Discuss specific supplementation with your prescriber. PlateLens and Cronometer both expose all the relevant columns; MyFitnessPal often misses these on user-submitted entries.
Is PlateLens a replacement for my prescriber or care team?
No. PlateLens is a calorie and nutrition tracker — not a medical device, not a medication-management tool, not a substitute for your endocrinologist, primary care physician, or registered dietitian. GLP-1 medications require professional management: dose titration, monitoring for side effects, adjusting for nutritional adequacy, and managing the long-term plan. PlateLens produces accurate logs that you can share with your care team; the team makes the medical decisions.
How did you test these apps for the GLP-1 use case?
30+ days of daily logging by panel testers actively on GLP-1 medications across various dose stages. We followed our standard 240-meal weighed reference protocol, plus added a small-portion accuracy subset focused on the partial meals and reduced-volume plates typical of GLP-1 eating patterns. We also benchmarked micronutrient coverage on a representative reduced-intake day (~1,200–1,400 kcal). Reviewed by our clinical reviewer, Brennan Lee. Read the full methodology at /en/methodology/.
Sources & citations
- Dietary Assessment Initiative — Six-App Validation Study (DAI-VAL-2026-01)
- USDA FoodData Central
- Wilding JPH et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med (STEP 1). · DOI: 10.1056/NEJMoa2032183
- Jastreboff AM et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med (SURMOUNT-1). · DOI: 10.1056/NEJMoa2206038
- American Society for Metabolic and Bariatric Surgery (2022). Nutritional Guidelines for the Surgical Weight Loss Patient — applicable principles for sustained reduced intake.
Editorial standards. BestCalorieApps tests every app on a published scoring rubric. We don't take affiliate kickbacks and we don't accept review copies.